Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

9.8%

28 terminated/withdrawn out of 287 trials

Success Rate

84.5%

-2.0% vs industry average

Late-Stage Pipeline

18%

53 trials in Phase 3/4

Results Transparency

1%

2 of 153 completed trials have results

Key Signals

40 recruiting2 with results20 terminated8 withdrawn

Enrollment Performance

Analytics

N/A
104(54.2%)
Phase 3
38(19.8%)
Phase 2
29(15.1%)
Phase 4
15(7.8%)
Phase 1
6(3.1%)
192Total
N/A(104)
Phase 3(38)
Phase 2(29)
Phase 4(15)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (287)

Showing 20 of 287 trials
NCT06947668Recruiting

Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel

Role: lead

NCT06969820Recruiting

Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT in Heel Spur With Plantar Fasciitis

Role: lead

NCT02528955Phase 2Completed

De-Intensification Radiotherapy Postoperative Head Neck

Role: lead

NCT06367257Not ApplicableRecruiting

App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy

Role: lead

NCT07721701Recruiting

Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers

Role: lead

NCT07705178Not ApplicableRecruiting

More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)

Role: lead

NCT07661940Phase 2Not Yet Recruiting

Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machine

Role: lead

NCT07643558Not ApplicableRecruiting

Effects of Dietary Supplementation With omega3-fatty Acids (Fish Oil) and Progressive Resistance Training on Skeletal Muscle Status in Gynaecological, Gastrointestinal and Urological Cancer Patients

Role: lead

NCT07406191Not ApplicableActive Not Recruiting

WB-EMS Effects on Cardiometabolic Risk Factors

Role: lead

NCT07352540Phase 2Active Not Recruiting

Single vs Triple Hyaluronic Acid in Knee Osteoarthritis

Role: lead

NCT06560801Phase 4Recruiting

Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation

Role: lead

NCT06051812Active Not Recruiting

Proteinuria and Renal Perfusion in Renal Transplant Recipients

Role: lead

NCT05460169Not ApplicableActive Not Recruiting

Renal Denervation in ADPKD- RDN-ADPKD Study

Role: lead

NCT07410247Recruiting

MPN Childhood Registry

Role: lead

NCT04264403Not ApplicableCompleted

Renal Denervation in Chronic Kidney Disease - RDN-CKD Study

Role: lead

NCT05897047Not ApplicableActive Not Recruiting

The smartNTx Trial:Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)

Role: lead

NCT06244758Phase 3Completed

Finerenone and Renal Oxidative Stress

Role: lead

NCT03386357Phase 2Terminated

Radiotherapy With Pembrolizumab in Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Role: lead

NCT06047236Recruiting

Immune Biomarker Study for Salivary Gland Carcinoma

Role: lead

NCT06030440Phase 2Recruiting

De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

Role: lead